1072833-64-7Relevant articles and documents
PROTEASOME INHIBITOR
-
Paragraph 0078-0079; 0082, (2020/06/30)
PROBLEM TO BE SOLVED: To provide a novel compound useful as a proteasome inhibitor. SOLUTION: The invention also provides a pharmaceutical composition comprising the compound, and a method of using the composition for treatment of various diseases. The compound is a compound of the general formula (I) or a pharmaceutical acceptable salt or boronic acid anhydride thereof. In the formula, Z1 and Z2 are each independently hydroxy, alkoxy, aryloxy or aralkoxy, or Z1 and Z2 together form a moiety derived from a boronic acid complexing agent. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT
Proteasome inhibitor
-
Paragraph 0079; 0082, (2017/03/08)
PROBLEM TO BE SOLVED: To provide a novel compound useful as a proteasome inhibitor. SOLUTION: The invention also provides a pharmaceutical composition comprising the compound, and a method of using the composition for treatment of various diseases. The compound is a compound of the general formula (I) or a pharmaceutical acceptable salt or boronic acid anhydride thereof. In the formula, Z1 and Z2 are each independently hydroxy, alkoxy, aryloxy or aralkoxy, or Z1 and Z2 together form a moiety derived from a boronic acid complexing agent. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPO&INPIT
PROTEASOME INHIBITORS
-
Page/Page column 24, (2009/04/25)
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.